InvestorsHub Logo
Followers 0
Posts 210
Boards Moderated 0
Alias Born 09/23/2010

Re: Calikush420 post# 917

Thursday, 10/04/2012 6:26:21 AM

Thursday, October 04, 2012 6:26:21 AM

Post# of 2495
imo this will take up to 52 weeks, ANTH wrote Patients will be treated in the controlled part of each study for 52 weeks after which they will have the option to receive additional treatment as part of an open-label, long-term, follow-up safety study. btw can they disclose partial results before meeting the endpoint?